GP2 may also be effective when administered in combination with Herceptin based therapeutics in HER2/neu 1-2+ patient populations or other HER2/neu expressing cancers. Excerpts of the poster are ...

Final 5 Year Data Set of GP2 Phase IIb Trial is Now Complete: Figure 1 of the poster shows a time series of the GP2 immunotherapy injections, adverse events (AE), immune response, and 100% disease ...